Biotechnology (6) | Trademark Agreements (6)
Browse by Company
Recent Contracts
-
Sublicense Agreement dated as of December 7, 2012 between Biostage, Inc. and Harvard Bioscience, Inc., and related Trademark License Agreement, dated December 19, 2002, by and...
(Biostage, Inc., Filed With SEC on March 7, 2023)
-
Master Trademark Assignment Agreement, dated May 5, 2022, by and among ICPT Inc., RXF Technologies, Inc. and Mercury Pharma
(INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on August 3, 2022)
-
Official USPTO Notice of Publication under 12(A) for the Trademark ProLectin
(BIOXYTRAN, INC, Filed With SEC on June 10, 2022)
-
BioXcel Trademark License Agreement, between the Company and BioXcel LLC, dated April 9, 2022
(BioXcel Therapeutics, Inc., Filed With SEC on May 9, 2022)
-
Fifth Amendment to Trademark License and Supply Agreement, effective September 30, 2020, between the Company and Mission Pharmacal Company
(Retrophin, Inc., Filed With SEC on November 5, 2020)
-
Fourth Amendment to Trademark License and Supply Agreement dated as of November 28, 2018, between Retrophin Inc. and Mission Pharmacal
(Retrophin, Inc., Filed With SEC on February 26, 2019)
